Abstract
The purpose of this study is to identify the clinical effects of Gyebongnyeong capsule in the treatment of primary dysmenorrhea patients. We studied ten patients visit Se-Myung University Oriental Medical Center from February, 2005 to March, 2005. Women with organic disease such as ut. myoma, ov. cyst and pelvic inflammatory disease were excluded from this study. We treated them with Gyebongnyeong capsule for two menstrual cycles. The severity of dysmenorrhea were measured by VAS (Visual Analog Scale) and Patient's Global Assessment. Gyebongnyeong capsule significantly decreased the severity of dysmenorrhea. Gyebongnyeong capsule did not show hepatic and renal virulence. This study shows that Gyebongnyeong capsule has remarkable effects on dysmenorrhea patients.